News

Pharmac is calling for new funding applications for medicines for rare disorders ahead of our Rare Disorders Advisory Committee meeting. We know that people with rare disorders face challenges including access to suitable health care and accessing effective medicines. We are committed to a regular call for applications for medicines for rare disorders. We are asking for new applications from pharmaceutical suppliers so we can consider taking them to our next meeting on  Wednesday   29 July...

Following feedback, Pharmac has decided not to proceed with a proposal to decline some low-ranked applications on the Options for Investment (OFI) list. We heard from a wide range of people - clinicians, professional groups, patient advocates, individuals and pharmaceutical companies. People told us that while they understood our aim was to improve transparency, they did not want us to remove funding applications from the OFI. We’ve listened carefully and appreciate the time and thought that...

Kia ora   We are writing to inform you of two new listings:   aripiprazole 300 mg and 400mg injection (Abilify Maintena)   Key Date: Both of these products will be listed (funded) from 1 January 2026   Key messages: Abilify Maintena can now be administered by intramuscular injection into either the gluteal or deltoid muscle. The previous listed (funded) products did not include the extra needle to use for deltoid  administration. The package with needle for deltoid administration was...

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 12 December 2025. It includes information on:  New updates Resolved Supply Issues Pharmac funding both Estradot and Estradiol TDP Mylan brands of oestradiol patches From 1 December 2025, the funded brands of oestradiol patches will be Estradiol TDP Mylan and Estradot. Everyone who uses funded oestradiol patches will need to use either of these brands. Pharmac have...

Acetylcysteine (DBL Acetylcysteine) Inj 200 mg per ml, 10 ml ampoule  (Pharmacode 2260794) Pfizer's DBL Acetylcysteine will not be available from late December 2025 to March 2026. An alternative has been listed. Amoxicillin (Ibiamox) Inj 250 mg vial  (Pharmacode: 2272628) Douglas, the supplier, expects to go out of stock of the following product by mid-December because of higher-than-normal demand and shipping delays. Resupply is expected by the end of December. Emtricitabine with tenofovir...

Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at  library@health.govt.nz . Thank you for reading the Health Improvement and Innovation Digest this year. Our...